Skip to content

Exercise Training Study of Patients With Claudicatio Intermittens

Randomized Clinical Trial on the Effects of Home-based Five Plus Exercise Training

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06448390
Enrollment
100
Registered
2024-06-07
Start date
2024-01-01
Completion date
2025-12-31
Last updated
2025-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Claudication, Intermittent

Brief summary

The aim of the study is to evaluate whether walking capacity in patients with intermittent claudication is improved more by home-based 5+ exercise training than by current recommendations of daily walking.

Detailed description

Patients with intermittent claudication will by a web-based program be randomized to either five plus training or walking at least 30 minutes three times per week. During the five plus training the participants are standing in front of a wall, which is used for support of the balance. The body is lifted with the calf musculature to the maximal height that the subject can achieve. This is repeated until pain is felt in the calf musculature. Following the initiation of pain the subject performs five extra repetitions. The five extra calf raises are included to secure induction of ischemia followed by reperfusion to secure maximal training effect. The patients are followed by absolute walking distance on a treadmill, quality of life questionnaire, and Ankle-brachial index.

Interventions

BEHAVIORALPhysical training

The patients are randomized to either walking 30 minutes 3 times a week or lifting the body to a tip toe position three times a day until pain in the claves and then add another five liftings before ending the session

Sponsors

Sykehuset i Vestfold HF
CollaboratorOTHER
Oslo University Hospital
CollaboratorOTHER
Haukeland University Hospital
CollaboratorOTHER
Sorlandet Hospital HF
CollaboratorOTHER_GOV
St. Olavs Hospital
CollaboratorOTHER
Sykehuset Ostfold
CollaboratorOTHER
Helse Stavanger HF
CollaboratorOTHER_GOV
Sykehuset Innlandet HF
CollaboratorOTHER
Drammen sykehus
CollaboratorOTHER
Alesund Hospital
CollaboratorOTHER
Sahlgrenska University Hospital
CollaboratorOTHER
Karolinska Institutet
CollaboratorOTHER
University Hospital, Linkoeping
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

The care provider instructs about the training version. Other people will evaluate the participants before and after the training period

Intervention model description

web-based prospective randomization between two groups of training for patients with Claudicatio intermittens

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Pain in the calves after 300 m, or less measured on a treadmill 2. Stable symptoms last 6 months or more 3. The pain must be gone within 5 minutes after the patients stop walking 4. Ankle-Brachial index at 0.7 or lower at rest 5. Using statins and antiplatelet drugs since at least 3 months 6. age\> 18 years 7. Signed consent

Exclusion criteria

1. pain in the hips or elsewhere outside the calves while walking 2. Remaining pain more than 5 minutes after stopped walking. 3. Impossible to compress the arteries while measruing ABI or ABI lower than 0.4 4. Use of statins and antiplatelet drugs less than 3 months 5. symptoms less than 6 months 6. Diabetes measured with HbA1c being over 48 mmol/mol (6%) 7. Revascularisation the last 6 months 8. Pain in the calves after longer than 300 m measured on a treadmill 9. Reduced mobility in the ankles 10. Reduced physical ability to perform a test on a treadmill. 11. Age less than 18 years 12. General conditions that impairs the ability to take part in a training study including Obesity, KOLS, heart disease, arthrosis, inflammatory joint diseases . 13. No Signed consent

Design outcomes

Primary

MeasureTime frameDescription
walking distance12 weeksMeasured on a tread mill before and after the training period
Quality of life12 weeksMeasured with a questionnaire (VASCUQOL-6) before and after the training period

Countries

Norway, Sweden

Contacts

Primary ContactErney Mattsson, Professor
erney.mattsson@gmail.com0046737854490
Backup ContactJoakim Nordanstig, Professor
joakim.nordanstig@vgregion.se+46708259496

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026